期刊文献+

Bcl-2 siRNA对淋巴瘤细胞系CA46凋亡的影响

Effect of bcl-2 siRNA on Apoptosis of Burkitt's Lymphoma Cell Line CA46
在线阅读 下载PDF
导出
摘要 本研究探讨bcl-2 siRNA对淋巴瘤细胞系CA46凋亡及bcl-2基因表达的影响。设计并合成1条siRNA,用阳离子脂质体法转染CA46细胞。转染后48小时收集CA46细胞,用流式细胞仪检测细胞凋亡及凋亡过程中线粒体跨膜电位改变,用RT-PCR方法和流式细胞仪分别检测CA46细胞bcl-2 mRNA和BCL-2蛋白的表达。结果表明:bcl-2 siRNA转染CA46细胞48小时后,CA46细胞出现凋亡且线粒体跨膜电位发生变化;bcl-2 mRNA和BCL-2蛋白表达均显著降低。结论:bcl-2 siRNA可特异性抑制淋巴瘤细胞CA46 bcl-2基因的表达,改变CA46细胞线粒体跨膜电位诱导其凋亡。 The aim of this study was to investigate the effect of bcl-2 siRNA on bcl-2 gene expression and apoptosis of lyrnphoma cell line CA46. A siRNA was designed and synthesized. Then siRNA was transfected into CA46 cells by cationic liposome. At 48 hours after transfection, apoptosis and mitochondria transmembrane potential of CA46 cells were detected by flow cytometry, the expression of bcl-2 mRNA and BCL-2 protein in CA46 cells were detected by RTPCR and flow cytometry respectively. The results showed that at 48 hours after transfection, apoptosis of CA46 cells occurred, mitochondria transmembrane potential changed. The expression of bcl-2 mRNA and BCL-2 protein in CA46 cells decreased significantly. In conclusion, bcl-2 siRNA depresses the expression of bcl-2 gene in CA46 cells specifically, then changes the mitochondria transmembrane potential, resulting in apoptosis of CA46 cells.
出处 《中国实验血液学杂志》 CAS CSCD 2009年第1期80-82,共3页 Journal of Experimental Hematology
关键词 BCL-2 SIRNA 淋巴瘤 CA46细胞系 细胞凋亡 bcl-2 siRNA lymphoma CA46 cell line apoptosis
  • 相关文献

参考文献8

  • 1Kluck RM, Bossy-Wetze E, Green DR, et al. The release of cytochrome c from mitochondria : a primary site for bcl-2 regulation of apoptosis. Science, 1997 ; 275 : 1132 - 1136.
  • 2Miyashita T, Reed JC. Bcl-2 oncoprotein blocks chemotherapy induced apoptosis in a human leukemia cell line. Blood, 1993 ;81:151 - 157.
  • 3Kiasa R J, Bally MB, Ng R, et al. Eradication of human non Hodgkin's lymphoma in SCID mice by Bcl-2 antisense oligonucletotides combined with Low-dose cyclophosphamide. Clin Cancer Res, 2000; 6:2492 -2500.
  • 4Zangemeister-Wittke U, Schenker T, Luedke GH, et al. Synergistic cytotoxicity of bcl-2 antisense oligonucleotides and etoposide, doxorubicin and cisplatin on small-cell lung cancer cell lines. Br J Cancer, 1998 ; 78 : 1035 - 1042.
  • 5Kitada S, Takayama S, De Riel K, et al. Reversal of chemoresistance of lymphoma cells by antisense-mediated reduction of bcl-2 gene expression. Antisense Res Dev, 1994 ; 4:71 - 79.
  • 6Leung S, Miyaka H, Zellweger T, et al. Synergistic chemosensitization and inhibition of progression to androgen independence by anti- sense Bcl-2 oligodeoxynucleotide and paclitaxel in the LNCaP prostate tumor model. Int J Cancer, 2001 ; 91:846 -850.
  • 7Lopes de Menezes DE, Hndon N, Mclntosh N, et al. Molecular and pharmacokinetic properties associated with the "The therapeutics of bcl-2 antisense oligonucleotide G3139 combined with free and liposomal doxorubicin". Clin Cancer Res, 2000 ; 6:2891 - 2902.
  • 8Leirdal M, Sioud M. Gene silencing in mammalian cells by performed small RNA duplexes. Biochem Biophys Res Commun, 2002; 295:744 - 748.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部